Evidence map›Paper›PMID 39273823›Full record

ArticleHealthcare (Basel, Switzerland)2024

COVID-19 Vaccine Uptake among People with Spinal Cord Injury and Dysfunction in Ontario, Canada: A Population-Based Retrospective Cohort Study.

Angela Mei, Arrani Senthinathan, Swaleh Hussain, Mina Tadrous, Vanessa K Noonan, Susan B Jaglal, Rahim Moineddin, B Catharine Craven, Sandra McKay, Lauren Cadel and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Healthcare (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Angela MeiDalla Lana School of Public Health, University of Toronto, Toronto, ON M5S 1A1, Canada.
Arrani SenthinathanLeslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada.ORCID 0000-0002-9304-3039
Swaleh HussainLeslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada.
Mina TadrousLeslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada.
Vanessa K NoonanInternational Collaboration on Repair Discoveries, Vancouver, BC V5Z 1M9, Canada.ORCID 0000-0003-3226-9218
Susan B JaglalICES, Toronto, ON M5T 3M6, Canada.
Rahim MoineddinICES, Toronto, ON M5T 3M6, Canada.ORCID 0000-0002-5506-084X
B Catharine CravenInstitute of Health Policy Management and Evaluation, University of Toronto, Toronto, ON M5T 3M6, Canada.ORCID 0000-0001-8234-6803
Sandra McKayVHA Home HealthCare, Toronto, ON M4S 1V6, Canada.ORCID 0000-0002-5073-3662
Lauren CadelLeslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada.ORCID 0000-0001-6925-8163
John ShepherdRehabilitation Science Institute, University of Toronto, Toronto, ON M5G 1V7, Canada.ORCID 0000-0001-8072-3775
Karen TuDepartment of Family and Community Medicine, University of Toronto, Toronto, ON M5G 1V7, Canada.ORCID 0000-0003-0883-4934
Sara J T GuilcherLeslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada.ORCID 0000-0002-9552-9139

Funding

CIHR 478336
6 · The paper itself

Abstract

Persons with disabilities experience numerous barriers to healthcare access including vaccine accessibility. The purpose of this study was to determine COVID-19 vaccine uptake in the spinal cord injury and disease (SCI/D) population of Ontario and identify potential factors influencing C OVID-19 vaccine uptake. This was a retrospective closed-cohort study using administrative health data on individuals with SCI/D of traumatic and non-traumatic causes to examine the monthly number of COVID-19 vaccine doses received between December 2020 and December 2023. Logistic regression analysis was used to examine the potential association between socio-demographic, clinical, and neighbourhood characteristics with initial COVID-19 vaccine receipt and booster dose uptake. By the end of the observation period in December 2023, 82.9% received the full two-dose coverage and 65.6% received at least one additional booster dose in a cohort of 3574 individuals with SCI/D. SCI/D individuals showed a comparable COVID-19 vaccine uptake percentage to the general population. Sociodemographic, clinical, and neighbourhood characteristics were associated with COVID-19 vaccine uptake in the SCI/D population, including age, type of injury, number of comorbidities, mental health history, and neighbourhood characteristics such as income. Further investigation is necessary to determine the causation effects of these relationships with vaccine uptake to address health equity concerns.

Indexed as

COVID-19 vaccinedisabilityhealth equityOntariosociodemographicsspinal cord injury and disease

Identifiers

PMID39273823
PMCPMC11395670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.